Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (23 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Sep 2021 – 20 Aug 2026, limited by Axis Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Value Fund | Nifty 500 |
|---|---|---|
| 28 Sep 2021 | ₹100.00 | ₹100.00 |
| 24 Feb 2022 | ₹92.99 | ₹91.26 |
| 23 Jul 2022 | ₹97.00 | ₹94.97 |
| 19 Dec 2022 | ₹104.90 | ₹104.37 |
| 17 May 2023 | ₹107.91 | ₹102.19 |
| 13 Oct 2023 | ₹127.03 | ₹115.20 |
| 10 Mar 2024 | ₹153.35 | ₹135.37 |
| 05 Aug 2024 | ₹176.68 | ₹149.33 |
| 01 Jan 2025 | ₹185.29 | ₹148.22 |
| 30 May 2025 | ₹180.48 | ₹151.05 |
| 26 Oct 2025 | ₹190.99 | ₹156.91 |
| 24 Mar 2026 | ₹175.38 | ₹139.56 |
| 20 Aug 2026 | ₹203.80 | ₹155.76 |
| Metric | Axis · Regular NAV ₹20.36 Very High risk ★★★★★ | Category median Value Fund · 23 funds |
|---|---|---|
| +10.17% | +2.35% | |
| +18.83% | +13.86% | |
| — | +13.50% | |
| — | +13.29% | |
| +15.66% | +14.30% | |
| +17.06% | — | |
| +21.61% | +16.80% | |
| — | +14.35% | |
| — | +14.21% | |
| Risk | ||
| 14.05% | 14.36% | |
| 0.88 | 0.51 | |
| 1.19 | 0.69 | |
| -20.84% | -40.31% | |
| Nifty 500 | — | |
| +5.87% | +1.91% | |
| 0.95 | 0.96 | |
| 114.2% | 101.5% | |
| 86.3% | 95.5% | |
| 2.33% | 2.28% | |
| ₹1,552Cr | ₹1,662Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 45% | 36% | |
| Krishnaa Narayan | — | |
| 28 Sep 2021 | — | |
| 87 | — | |
| 33.1% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.